J. Fryklund

835 total citations
24 papers, 705 citations indexed

About

J. Fryklund is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, J. Fryklund has authored 24 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Surgery. Recurrent topics in J. Fryklund's work include Ion Transport and Channel Regulation (10 papers), Drug Transport and Resistance Mechanisms (9 papers) and Helicobacter pylori-related gastroenterology studies (8 papers). J. Fryklund is often cited by papers focused on Ion Transport and Channel Regulation (10 papers), Drug Transport and Resistance Mechanisms (9 papers) and Helicobacter pylori-related gastroenterology studies (8 papers). J. Fryklund collaborates with scholars based in Sweden, United States and United Kingdom. J. Fryklund's co-authors include B. Wallmark, Håkan Larsson, George Sachs, Carin Briving, Keith Munson, R J Jackson, John Mendlein, E. Rabon, Enar Carlsson and Thomas C. Kühler and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Analytical Biochemistry.

In The Last Decade

J. Fryklund

23 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Fryklund Sweden 13 338 274 156 130 77 24 705
Pia Lorentzon Sweden 11 328 1.0× 196 0.7× 165 1.1× 130 1.0× 31 0.4× 16 614
Marie Besancon United States 14 442 1.3× 394 1.4× 331 2.1× 124 1.0× 48 0.6× 17 810
Kiyoshi Oketani Japan 11 169 0.5× 145 0.5× 75 0.5× 73 0.6× 69 0.9× 22 446
Joan Malmstrøm Denmark 16 206 0.6× 245 0.9× 145 0.9× 22 0.2× 170 2.2× 36 850
C D Schteingart United States 18 187 0.6× 365 1.3× 56 0.4× 534 4.1× 38 0.5× 31 824
Takehiro Oshima Japan 13 408 1.2× 82 0.3× 111 0.7× 97 0.7× 24 0.3× 22 797
Lisa Gruber Germany 17 319 0.9× 83 0.3× 74 0.5× 68 0.5× 72 0.9× 21 677
M Armstrong United States 9 204 0.6× 200 0.7× 13 0.1× 257 2.0× 77 1.0× 11 651
Takeo Yamaguchi Japan 15 213 0.6× 137 0.5× 23 0.1× 23 0.2× 28 0.4× 61 587
Ulrike Gutjahr Germany 15 234 0.7× 205 0.7× 24 0.2× 505 3.9× 27 0.4× 15 759

Countries citing papers authored by J. Fryklund

Since Specialization
Citations

This map shows the geographic impact of J. Fryklund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Fryklund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Fryklund more than expected).

Fields of papers citing papers by J. Fryklund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Fryklund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Fryklund. The network helps show where J. Fryklund may publish in the future.

Co-authorship network of co-authors of J. Fryklund

This figure shows the co-authorship network connecting the top 25 collaborators of J. Fryklund. A scholar is included among the top collaborators of J. Fryklund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Fryklund. J. Fryklund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lundin, Anders, David Gustafsson, J. Fryklund, et al.. (2018). Plasminogen binding inhibitors demonstrate unwanted activities on GABA A and glycine receptors in human iPSC derived neurons. Neuroscience Letters. 681. 37–43.
2.
Lindberg, Per, David Keeling, J. Fryklund, et al.. (2003). Esomeprazole — enhanced bio‐availability, specificity for the proton pump and inhibition of acid secretion. Alimentary Pharmacology & Therapeutics. 17(4). 481–488. 53 indexed citations
3.
Hallén, Stefan, et al.. (2000). Cytostar-T Scintillating Microplate Assay for Measurement of Sodium-Dependent Bile Acid Uptake in Transfected HEK-293 Cells. Analytical Biochemistry. 282(1). 94–101. 15 indexed citations
4.
Sjöström, Jan-Eric, J. Fryklund, Thomas C. Kühler, & Henrik Larsson. (1996). In vitro antibacterial activity of omeprazole and its selectivity for Helicobacter spp. are dependent on incubation conditions. Antimicrobial Agents and Chemotherapy. 40(3). 621–626. 30 indexed citations
5.
Kühler, Thomas C., et al.. (1995). Structure-Activity Relationship of Omeprazole and Analogs as Helicobacter pylori Urease Inhibitors. Journal of Medicinal Chemistry. 38(25). 4906–4916. 82 indexed citations
6.
Fryklund, J., et al.. (1993). Effects of chloride transport inhibitors on intestinal fluid and ion transport in vivo and in vitro. Acta Physiologica Scandinavica. 149(3). 365–376. 9 indexed citations
7.
Fryklund, J., et al.. (1992). Omeprazole Does Not Cause Unscheduled DNA Synthesis in Rabbit Parietal Cells in Vitro. Scandinavian Journal of Gastroenterology. 27(6). 521–528. 8 indexed citations
8.
Larsson, Håkan, J. Fryklund, Herbert F. Helander, & B. Wallmark. (1991). Partial pronase digestion of rat gastric mucosa isolates cells undergoing replicative DNA synthesis. Mutagenesis. 6(1). 3–9. 8 indexed citations
9.
Wallmark, B. & J. Fryklund. (1990). [41] Pharmacological agents of gastric acid secretion: Receptor antagonists and pump inhibitors. Methods in enzymology on CD-ROM/Methods in enzymology. 191. 721–738. 1 indexed citations
10.
Wallmark, B., Henrik Larsson, Gerhard Andersson, J. Fryklund, & H. F. Helander. (1990). Tritiated Thymidine Incorporation into DNA in Rat Gastric Mucosal Cells. Digestion. 47(1). 39–44. 3 indexed citations
11.
Fryklund, J., Karin Gedda, D. B. McNair Scott, George Sachs, & B. Wallmark. (1990). Coupling of H(+)-K(+)-ATPase activity and glucose oxidation in gastric glands. American Journal of Physiology-Gastrointestinal and Liver Physiology. 258(5). G719–G727. 16 indexed citations
12.
Holmgren, Jan, J. Fryklund, & Håkan Larsson. (1989). Gamma‐Interferon‐Mediated Down‐Regulation of Electrolyte Secretion by Intestinal Epithelial Cells: A Local Immune Mechanism?. Scandinavian Journal of Immunology. 30(4). 499–503. 55 indexed citations
13.
Larsson, Håkan, Enar Carlsson, B. Ryberg, J. Fryklund, & B. Wallmark. (1988). Rat parietal cell function after prolonged inhibition of gastric acid secretion. American Journal of Physiology-Gastrointestinal and Liver Physiology. 254(1). G33–G39. 59 indexed citations
14.
Fryklund, J., H. F. Helander, B. Elander, & B. Wallmark. (1988). Function and structure of parietal cells after H+-K+-ATPase blockade. American Journal of Physiology-Gastrointestinal and Liver Physiology. 254(3). G399–G407. 17 indexed citations
15.
Fryklund, J., Karin Gedda, & B. Wallmark. (1988). Specific labelling of gastric H+,K+-ATPase by omeprazole. Biochemical Pharmacology. 37(13). 2543–2549. 45 indexed citations
16.
Wallmark, B., Carin Briving, J. Fryklund, et al.. (1987). Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole.. Journal of Biological Chemistry. 262(5). 2077–2084. 197 indexed citations
17.
Fryklund, J. & B. Wallmark. (1986). Sulfide and sulfoxide derivatives of substituted benzimidazoles inhibit acid formation in isolated gastric glands by different mechanisms.. Journal of Pharmacology and Experimental Therapeutics. 236(1). 248–253. 10 indexed citations
18.
Skoubo-Kristensen, E. & J. Fryklund. (1985). Adrenergic stimulation of pepsinogen release from rabbit isolated gastric glands. Naunyn-Schmiedeberg s Archives of Pharmacology. 330(1). 37–41. 5 indexed citations
19.
Fryklund, J., B. Wallmark, Håkan Larsson, & Herbert F. Helander. (1984). Effect of omeprazole on gastric secretion in H+,K+-ATPase and in pepsinogen-rich cell fractions from rabbit gastric mucosa. Biochemical Pharmacology. 33(2). 273–280. 42 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pia Lorentzon Breakdown of academic impact, for papers by Marie Besancon Breakdown of academic impact, for papers by Kiyoshi Oketani Breakdown of academic impact, for papers by Joan Malmstrøm Breakdown of academic impact, for papers by C D Schteingart Breakdown of academic impact, for papers by Takehiro Oshima Breakdown of academic impact, for papers by Lisa Gruber Breakdown of academic impact, for papers by M Armstrong Breakdown of academic impact, for papers by Takeo Yamaguchi Breakdown of academic impact, for papers by Ulrike Gutjahr
Rankless by CCL
2026